3E0A30M
Introduction Bone Marrow to Monoclonal Antibody with Antineoplastic, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 3 Administration |
| Body System | E Physiological Systems and Anatomical Regions |
| Operation | 0 Introduction |
| Body Part | A Bone Marrow |
| Approach | 3 Percutaneous |
| Device | 0 Antineoplastic |
| Qualifier | M Monoclonal Antibody |
Operation Definition
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
Procedure Overview
Introduction covers putting a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance into or onto a body region, other than blood or blood products, which fall under Transfusion instead. This wide-ranging family includes things like injecting anesthesia, infusing chemotherapy, instilling contrast for imaging, delivering anti-infective medications, or providing nutritional formula through a feeding route.
Because it spans so many substance types and delivery sites, this is one of the most frequently used families in the Administration section. A patient might encounter it during an epidural injection, a course of intravenous antibiotics, contrast dye given before a CT scan, or tube feeding after surgery; each represents a substance being placed into the body to achieve a specific therapeutic or diagnostic goal rather than a physical alteration of tissue.
Anatomy & Axis Detail
Bone Marrow
Bone marrow introduction refers to substances instilled directly into the marrow space, most notably during intraosseous access for emergency fluid or medication delivery when peripheral intravenous access is difficult, or for local anesthetic and antibiotic administration into a specific bone. The marrow cavity's rich vascular network allows rapid systemic absorption, which is why intraosseous routes are favored in trauma or pediatric resuscitation. This is distinct from bone marrow aspiration or biopsy, which are diagnostic extractions rather than administrations, and from introduction into a vein even though systemic circulation is reached, because the access point and technique differ. Documentation should specify the bone accessed and confirm the substance was delivered into the marrow rather than a joint or soft tissue nearby.
Approach: Percutaneous
In Administration, Percutaneous denotes a substance delivered by needle injection through the skin, such as an intramuscular or subcutaneous injection, without cutting or scope guidance. It differs from External, where the substance is applied to the skin surface itself, and from Via Natural or Artificial Opening, where it is introduced through an orifice rather than through a puncture.
Substance: Antineoplastic
Antineoplastic designates administration of a substance intended to destroy or inhibit malignant cells, encompassing chemotherapy agents given systemically or regionally as part of cancer treatment. It is distinguished from Destructive Agent, which ablates tissue by direct chemical or physical action rather than targeted cytotoxic pharmacology, and from Radioactive Substance, which achieves its effect through ionizing radiation rather than chemical action.
Qualifier: Monoclonal Antibody
Identifies the substance administered as a monoclonal antibody, a lab-engineered protein designed to bind a single specific target such as a tumor antigen or inflammatory mediator. It is distinct from the narrower Other Therapeutic Monoclonal Antibody qualifier, reserved for antibody products not captured elsewhere, and from general Other Antineoplastic agents that work through different mechanisms.
Coding & Documentation
Correct code assignment depends on identifying three things from the documentation: the substance given, matched to the correct qualifier value; the specific body region or route receiving it; and the approach used, such as percutaneous injection or an existing catheter. Physician orders and medication administration records are the primary support. The most common errors involve selecting an imprecise substance qualifier, for example coding a general anti-infective when the documentation specifies a particular drug category with its own value, or misidentifying the body region when a substance is delivered systemically versus locally, such as an intra-articular injection versus an intravenous one.
Commonly Confused With
This family is easily confused with Transfusion, but any blood or blood product is excluded here and must be coded under Transfusion instead, regardless of how it is delivered. It is also confused with routine medication administration that some facilities do not code separately when it is considered standard nursing care rather than a notable procedural event; coders should apply their facility's guidelines to determine which introductions rise to the level of a codable procedure.